Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy

Diabetes

Volumn 48, Issue 12, 1999, Pages 2454-2462

  Fine, Esther L ^a   Horal, Melissa ^a   Chang, Tara I ^a   Fortin, Gary ^a   Loeken, Mary R ^a,b  

^a JOSLIN DIABETES CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; APOPTOSIS; ARTICLE; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; MOUSE; NEURAL TUBE DEFECT; NEUROEPITHELIUM; NONHUMAN; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0033513480     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.12.2454     Document Type: Article

References (71)

1. Miller E, Hare JW, Cloherty JP, Dunn PJ, Gleason RE, Soeldner JS, Kitzmiller JL: Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 304:1331-1334, 1981
2. Kitzmiller JL, Cloherty JP, Younger MD, Tabatibaii A, Rothchild SB, Sosenko I, Epstein MF, Singh S, Neff RK: Diabetic pregnancy and perinatal morbidity. Am J Obstet Gynecol 131:560-580, 1978
3. Miodovnik M, Mimouni F, Dignan PSJ, Berk MA, Ballard JL, Siddiqi TA, Khoury J, Tsang RC: Major malformations in infants of IDDM women: vasculopathy and early first-trimester poor glycemic control. Diabetes Care 11:713-718, 1988
4. Lucas MJ, Leveno KJ, Williams L, Raskin P, Whalley PJ: Early pregnancy glycosylated hemoglobin, severity of diabetes, and fetal malformations. Am J Obstet Gynecol 161:426-431, 1989
5. Damm P, Molsted-Pedersen L: Significant decrease in congenital malformations in newborn infants of an unselected population of diabetic women. Am J Obstet Gynecol 161:1163-1167, 1989
6. Mills JL, Knopp RH, Simpson JL, Jovanovic-Peterson L, Metzger BE, Holmes LB, Aarons JH, Brown Z, Reed GF, Bieber FR, Van Allen M, Holzman I, Ober C, Peterson CM, Withiam MJ, Duckles A, Mueller-Heubach E, Polk BF: Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med 318:671-676, 1988
7. Becerra JE, Khoury MJ, Cordero JF, Erickson JD: Diabetes mellitus during pregnancy and the risks for the specific birth defects: a population-based case-control study. Pediatrics 85:1-9, 1990
8. Hawthorne G, Robson S, Ryall EA, Sen D, Roberts SH, Ward Platt MP: Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit, 1994. BMJ 315:279-281, 1997
9. Hollingsworth DR: Pregnancy, Diabetes, and Birth: A Management Guide. Hollingsworth DR, Ed. Baltimore, Williams and Wilkins, 1992
10. Phelan SA, Ito M, Loeken MR: Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes 46:1189-1197, 1997
11. Cai J, Phelan SA, Hill AL, Loeken MR: Identification of Dep-1, a new gene that is regulated by the transcription factor, Pax-3, as a marker for altered embryonic gene expression during diabetic pregnancy. Diabetes 47:1803-1805, 1998
12. Hill AL, Phelan SA, Loeken MR: Reduced expression of Pax-3 is associated with overexpression of cdc46 in the mouse embryo. Dev Genes Evol 208:128-134, 1998
13. Goulding M, Sterrer S, Fleming J, Balling R, Nadeau J, Moore KJ, Brown SDM, Steel KP, Gruss P: Analysis of the Pax-3 gene in the mouse mutant splotch. Genomics 17:355-363, 1993
14. Epstein DJ, Vogan KJ, Trasler DG, Gros P: A mutation within intron 3 of the Pax-3 gene produces aberrantly spliced mRNA transcripts in the splotch (Sp) mouse mutant. Proc Natl Acad Sci U S A 90:532-536, 1993
15. Epstein DJ, Vekemans M, Gros P: Splotch (Sp-2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell 67:767-774, 1991
16. Vogan KJ, Epstein DJ, Trasler DG, Gros P: The Splotch-Delayed (Sp-d) mouse mutant carries a point mutation within the paired box of the Pax-3 gene. Genomics 17:364-369, 1993
17. Greene MF, Hare JW, Cloherty JP, Benacerraf BR, Soeldner JS: First-trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology 39:225-231, 1989
18. The Diabetes Control and Complications Trial Group: Pregnancy outcomes in the Diabetes Control and Complications Trial. Am J Obstet Gynecol 174:1343-1353, 1996
19. Eriksson UJ, Hakan Borg LA, Forsberg H, Styrud J: Diabetic embryopathy: studies with animal and in vitro models. Diabetes 40 (Suppl. 2):94-98, 1991
20. Strieleman PJ, Metzger BE: Glucose and scyllo-inositol impair phosphoinositide hydrolysis in the 10.5-day cultured rat conceptus: a role in dysmorphogenesis. Teratology 48:267-278, 1993
21. Eriksson UJ, Borg LAH: Diabetes and embryonic malformations: role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes 42:411-419, 1993
22. Sadler TW, Hunter ESI, Wynn RE, Phillips LS: Evidence for multifactorial origin of diabetes-induced embryopathies. Diabetes 38:70-74, 1989
23. Wentzel P, Eriksson UJ: Insulin treatment fails to abolish the teratogenic potential of serum from diabetic rats. Eur J Endocrinol 134:459-466, 1996
24. Buchanan TA, Denno KM, Sipos GF, Sadler TW: Diabetic teratogenesis: in vitro evidence for a multifactorial etiology with little contribution from glucose per se. Diabetes 43:656-660, 1994
25. Plehwe WE, Storey GN, Shearman RP, Turtle JR: Outcome of pregnancy complicated by diabetes: experience with 232 patients in a 4 year period. Diabetes Res 1:67-73, 1984
26. Gibson JM, Westwood M, Crosby SR, Gordon C, Holly JM, Fraser W, Anderson C, White A, Young RJ: Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 80:1369-1375, 1995
27. Bang P, Brismar K, Rosenfeld RG, Hall K: Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with non-insulin-dependent diabetes mellitus versus healthy nonobese and obese subjects. J Clin Endocrinol Metab 78:960-967, 1994
28. Sivitz WI, DeSautel SL, Kayano T, Bell GI, Pessin JE: Regulation of glucose transporter messenger RNA levels in rat adipose tissue by insulin. Mol Endocrinol 4:583-588, 1990
29. Napoli R, Hirshman MF, Horton ES: Mechanisms and time course of impaired skeletal muscle glucose transport activity in streptozocin diabetic rats. J Clin Invest 96:427-437, 1995
30. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501, 1992
31. Goulding MD, Chalepakis G, Deutsch U, Erselius JR, Gruss P: Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J 10:1135-1147, 1991
32. Laborda J: 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucl Acids Res 19:3998, 1991
33. Shum L, Sadler TW: Biochemical basis for D,L,-beta-hydroxybutyrate-induced teratogenesis. Teratology 42:553-563, 1990
34. Styrud J, Thunberg L, Nybacka O, Eriksson UJ: Correlations between maternal metabolism and deranged development in the offspring of normal and diabetic rats. Pediatr Res 37:343-353, 1995
35. Reece E, Eriksson U: The pathogenesis of diabetes-associated congenital malformations. Obstet Gynecol Clin North Am 23:29-45, 1996
36. Reece E, Homko C, Wu Y: Multifactorial basis of the syndrome of diabetic embryopathy. Teratology 54:171-182, 1996
37. Hunter ES, Phillips LS, Goldstein S, Sadler TW: Altered visceral yolk sac function produced by a low-molecular-weight somatomedin inhibitor. Teratology 43:331-340, 1991
38. Engstrom E, Haglund A, Eriksson UJ: Effects of maternal diabetes or in vitro hyperglycemia on uptake of palmitic and arachidonic acid by rat embryos. Pediatr Res 30:150-153, 1991
39. Goldman AS, Goto MP: Biochemical basis of the diabetic embryopathy. Israel J Med Sci 27:469-477, 1991
40. Sussman I, Matschinsky FM: Diabetes affects sorbitol and myo-inositol levels of neuroectodermal tissue during embryogenesis in rat. Diabetes 37:974-981, 1988
41. Reece E, Homko C, Wu U, Wiznitzer A: The role of free radicals and membrane lipids in diabetes-induced congenital malformations. J Soc Gynecol Invest 5:178-187, 1998
42. King GL, Shiba T, Oliver J, Inoguchi T, Bursell SE: Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus. Ann Rev Med 45:179-188, 1994
43. Kunisaki M, Bursell S-E, Clermont AC, Ishii H, Ballas LM, Jirousek MR, Umeda F, Naata H, King GL: Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am J Physiol 269:E239-E246, 1995
44. Kunisaki M, Fumio U, Nawata H, King GL: Vitamin E normalizes diacylglycerol-protein kinase C activation induced by hyperglycemia in rat vascular tissues. Diabetes 45:S117-S119, 1996
45. Kowluru RA, Jirousek MR, Stramm L, Farid N, Engerman RL, Kern TS: Abnormalities of retinal metabolism in diabetes or experimental galactosemia. V. Relationship between protein kinase C and ATPases. Diabetes 47:464-469, 1998
46. Kamal K, Du W, Mills I, Sumpio BE: Antiproliferative effect of elevated glucose in human microvascular endothelial cells. J Cell Biochem 71:491-501, 1998
47. Nishio Y, Waren CE, Buczek-Thomas JA, Rulfs J, Koya D, Aiello LP, Feener EP, Miller TB Jr, Dennis JW, King GL: Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissue. J Clin Invest 96:1759-1767, 1995
48. Cooper ME: Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 352:213-219, 1998
49. Furth AJ: Glycated proteins in diabetes. Br J Biomed Sci 54:192-200, 1997
50. Chappey O, Dosquet C, Wautier MP, Wautier JL: Advanced glycation end products, oxidant stress and vascular lesions. Eur J Clin Invest 27:97-108, 1997
51. Wautier JL, Guillausseau PJ: Diabetes, advanced glycation end products and vascular disease. Vasc Med 3:131-137, 1998
52. Lee AT, Cerami A: Elevated glucose 6-phosphate levels are associated with plasmid mutations in vivo. Proc Natl Acad Sci U S A 84:8311-8314, 1987
53. Lee AT, Plump A, DeSimone C, Cerami A, Bucala R: A role for DNA mutations in diabetes-associated teratogenesis in transgenic embryos. Diabetes 44:20-24, 1995
54. Lee AT, Reis D, Eriksson UJ: Hyperglycemia-induced embryonic dysmorphogenesis correlates with genomic DNA mutation frequency in vitro and in vivo. Diabetes 48:371-376, 1999
55. Eriksson UJ, Borg LAH: Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia 34:325-331, 1991
56. Eriksson U, Siman CM: Pregnant diabetic rats fed the antioxidant butylated hydroxytoluene show decreased occurrence of malformations in offspring. Diabetes 45:1497-1502, 1996
57. Hagay ZJ, Weiss Y, Zusman I, Peled-Kamar M, Reece EA, Eriksson UJ, Groner Y: Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. Am J Obstet Gynecol 173:1036-1041, 1995
58. Sivan E, Reece EA, Wu Y-K, Homko CJ, Polansky M, Borenstein M: Dietary vitamin E prophylaxis and diabetic embryopathy: morphologic and biochemical analysis. Am J Obstet Gynecol 175:793-799, 1996
59. Wentzel P, Thunberg L, Eridsson UJ: The teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture. Diabetologia 40:7-14, 1997
60. Eriksson UJ: The antioxidants Trolox and N-acetylcysteine protect rat embryos from the teratogenic effects of a diabetic environment in vitro (Abstract). Diabetes 43 (Suppl. 1):136A, 1984
61. Lee KS, Buck M, Houglum K, Chojkier M: Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 96:2461-2468, 1995
62. Salnikow K, Gao M, Voitkun V, Huang X, Costa M: Altered oxidative stress responses in nickel-resistant mammalian cells. Cancer Res 54:6407-6412, 1994
63. Tacchini L, Poghiaghi G, Radice L, Anzon E, Bernelli-Zazzera A: Differential activation of heat-shock and oxidation-specific stress genes in chemically induced oxidative stress. Biochem J 309:453-459, 1995
64. Wu X, Bishopric NH, Discher DJ, Murphy BJ, Webster KA: Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol Cell Biol 16:1035-1046, 1996
65. Kambe F, Nomure Y, Okamot T, Seo H: Redox regulation of thyroid-transcription factors, Pax-8 and TTF-1, is involved in their increased DNA-binding activities by thyrotropin in rat thyroids FRTL-5 cells. Mol Endocrinol 10:801-812, 1996
66. Cox LS, Hupp T, Midgley CA, Lane DP: A direct effect of activated human p53 on eukaryotic DNA replication. EMBO J 14:2099-2105, 1995
67. Jayaraman L, Murthy KG, Zhu C, Curran T, Xanthoudakis S, Prives C: Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev 11:558-570, 1997
68. Hammes HP, Federoff HJ, Brownlee M: Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med 1:527-534, 1995
69. Friedman EA, Brown CD, Berman DH: Erythropoietin in diabetic macular edema and renal insufficiency. Am J Kidney Dis 26:202-208, 1995
70. Williamson JR, Chang K, Frangos M, Hasan HS, Ido Y, Kawamura T, Nyengaard JR, van den Enden M, Kilo C, Tilton RG: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801-813, 1993
71. Ebert BL, Bunn HF: Regulation of transcription by hypoxia requires a multi-protein complex that includes hypoxia-inducible factor 1, and adjacent transcription factor, and p300/CREB binding protein. Mol Cell Biol 18:4089-4096, 1998